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Clinical and experimental data indicate that a subset of innate lymphocytes, natural killer (NK) cells, plays a crucial role in the
response against herpesviruses, especially cytomegaloviruses (CMV). Indeed, in mice, NK cells, due to the expression of germline
encoded Ly49 receptors, possess multiple mechanisms to recognize CMV infection. Classically, this results in NK cell activation
andthedestruction oftheinfected cells.Morerecently, however,thisuniquehost-pathogeninteractionhaspermitted thediscovery
ofnovelaspects ofNK cell biology, implicatingthem inthe regulation ofadaptive immuneresponses as well as inthe development
of immunological memory. Here, we will concisely review the newly acquired evidence pertaining to NK cell Ly49-dependent
recognition of MCMV-infected cell and the ensuing NK cell regulatory responses.
If one way be better than another, that you may be sure is nature’s way.
Aristotle
1.Introduction
Naturalkiller(NK)cellsconstituteauniqueeﬀectorlympho-
cyte lineage, classically deﬁned as part of the innate immune
system. Their importance is well characterized in the con-
text of health, under normal physiological conditions. For
instance, NK cells are involved in tumor surveillance, given
their natural cytotoxicity against neoplasms. In pregnancy,
NK cells account for 70% of decidual leukocytes; they are
thought to mediate trophoblast invasion into the uterine
lining and the modiﬁcation of maternal spiral arteries [1].
In addition to their implication in these crucial components
of homeostasis and normal development, NK cells are
well known for their considerable role in defense against
infection.
Infection with a wide variety of pathogens can be limited
by the action of NK cells, speciﬁcally intracellular microor-
ganisms. Indeed, NK cells play a substantial role in the initial
control of both bacterial (e.g., Listeria monocytogenes)a n d
parasitic (e.g., Plasmodium species) spread [2]. Yet, in the
context of infection, the hallmark of NK cells remains their
potent antiviral activity. NK cells participate in the clear-
ance of many diﬀerent viruses (human immunodeﬁciency
virus, coxsackievirus, inﬂuenza or poxviruses, etc.), but
their contribution is indispensable with regards to infection
with members of the Herpesviridae family (herpes sim-
plex virus (HHV-1/2), varicella zoster virus (HHV-3), and
cytomegalovirus (HHV-5)) [2]. Plentiful evidence supports
this, namely, the cases of two young patients suﬀering from
numerous and recurrent herpesviral infections due to their
nonfunctional NK cells [3, 4] .I nm i c e ,N Kc e l ld e p l e t i o n
and adoptive transfer have long been known to increase,
respectively, susceptibility and resistance to mouse CMV
(MCMV).
The antiviral activity of NK cells relies on the various
eﬀector functions induced following their activation. On the2 Journal of Biomedicine and Biotechnology
one hand, NK cells secrete several cytokines, such as IFN-
γ,M I P 1 - α/β, RANTES, IL-10, activation-induced T-cell-
derived chemokine-related cytokine (ATAC, lymphotactin),
and others. On the other hand, NK cells display strong
cytotoxicity.Indeed, theycan kill virus-infected cells without
prior activation, and they do so via a number of mech-
anisms, namely exocytosis of perforin-granzymes granules
and signaling through members of the TNF death receptor
family [5]. Yet, cytokine production and cytotoxicity must
necessarily be preceded by the recognition of infected cells
by NK lymphocytes, a phenomenon that has mostly been
studied using a mouse model of infection.
CMVs are prototypical β-subgroup members of the
Herpesviridae family. Given the nonredundant role played by
NK cells in resolving infections with these viruses, it is not
surprising that CMVs would be perfect candidates for the
study of NK cell responses. Unfortunately, the strict species
speciﬁcity of CMVs precludes experimental infection of
mice with human CMV (HCMV). Yet, MCMV shares many
features with its human counterpart, including genome
structure and disease manifestations [6]. Both are natural
pathogens of their respective host and have coevolved with
themfor eons. Moreover, both viruses have developedvaried
and analogous immune-evasion mechanisms that heavily
implicate NK cells [7]. Therefore, early MCMV infection
has become an established model to study NK cells and,
more speciﬁcally, their impressive ability to distinguish self
from nonself through their germ-line encoded receptors. In
addition, at later times post-infection, this model reveled the
unforeseen involvement of NK cells in the adaptive immune
responses.
NK cells discriminate between infected and healthy
cells using an extensive panel of cell surface receptors,
both activating and inhibitory. Among the various receptor
families involved in this process, Ly49 receptors have proven
themselvestobeparticularlyimportantforMCMVdetection
by murine NK cells. These polygenic and polymorphic
receptors are clustered at the Natural Killer Cell Complex
(NKC) on mouse chromosome 6 [8]. They are stochastically
expressed as disulﬁde-linked homodimers primarily on the
surface of NK cells, but also on subsets of monocytes,
macrophages, dendritic cells (DCs), and T cells [9]. In terms
of ligand speciﬁcity, inhibitory Ly49 receptors recognize self-
MHC class I molecules (MHCI, also called H-2 in mice),
whereas their activating counterparts can bind to various
protein determinants of infection.
Ly49 receptors are structurally classiﬁed as type II trans-
membrane, C-type lectin-like proteins. Their extracellular
domain is comprised of a ﬂexible stalk and a Natural Killer
Domain (NKD), which provides ligand binding speciﬁcity
and is structurally conserved among all members of the Ly49
f a m i l y .Y e t ,a c t i v a t i n ga n di n h i b i t o r yr e c e p t o r sd i ﬀer with
regards to their intracellular domains. Indeed, inhibitory
Ly49 receptors possess an immunoreceptor tyrosine-based
inhibition motif (ITIM) within their intracellular domain.
Conversely, activating Ly49 receptors lack this ITIM motif;
instead, a positively charged arginine residue in their
transmembrane domain interacts with the DAP12/DAP10
adaptor proteins, which bears an immunoreceptor tyrosine-
based activation motif (ITAM).
During infection, Ly49 receptor triggering leads to the
initiation of a signaling cascade, the result of which is
either inhibition or activation of the NK cell. In the case
of both activating and inhibitory receptors, the ﬁrst step of
this cascade is the phosphorylation of the tyrosine residue
contained in their respective ITAM or ITIM, most likely
by a Src family kinase [5]. This phosphorylation recruits
either SHIP-1, SHP-1, or SHP-2 in the case of inhibitory
receptors, or Syk, ZAP-70 and PI(3)K or Grb2 for activating
receptors. In both cases, numerous downstream eﬀectors are
involved. The end result of inhibitory receptor triggering
is the dephosphorylation of ITAMs linked to activating
NK receptors and the prevention of Ca2+ inﬂux, degranu-
lation, cytokine production, and NK cell proliferation. In
opposition, activating Ly49 receptor engagement induces
the reorganization of the actin cytoskeleton to enable cell
polarization and the release of cytolytic granules, as well as
the transcription of many cytokine and chemokine genes.
Of note, inhibition is by far the most common signal
received by NK cells over the course of their lifetime. More-
over,duringNKcelldevelopment,bindingofinhibitoryLy49
receptors to self-MHCI molecules renders them functional,
that is to say capable of cytokine secretion (e.g., IFN-γ)a n d
cytotoxic killing [10]. This model, called NK cell education
or licensing, postulates that the stronger the inhibitory
Ly49-self MHCI interactions are, the more competent the
NK cell will emerge. The immune response which follows
MCMV infection relies on the interplay of soluble factors
and numerous cell types, among them NK cells. In the
early innate response, Ly49 receptors are critical for NK cell
activation, which in turn controls viral proliferation, due to
their ability to recognize various viral and self-ligands. Nev-
ertheless, initial NK cell proliferation is Ly49-independent
and nonselective, while the subsequent preferential NK cell
proliferation is driven by activating Ly49 receptors. At later
stages of the infection, NK cell secreted cytokines and apt
virus control allows them to regulate the adaptive response.
Most surprisingly, Ly49-mediated activation of NK cells also
allows the generation of NK cells with several characteristics
seen in memory T cells (Figure 2(a)).
All of these aspects of MCMV-Ly49-driven NK cell
responses will be examined in this paper. Most importantly,
evidence will be presented to highlight the previously
unanticipated sophistication of the NK cell response against
infection, redeﬁning the established concepts of innate and
adaptive immunity.
2.Immediate Nonspeciﬁc NKCellsResponse
to MCMV Infection
From its initial peripheral sites of entry, MCMV spreads to
the lymph nodes and via the bloodstream to the spleen,
and the liver, infecting a broad spectrum of cell types.
Macrophages, hepatocytes, and reticular ﬁbroblasts are some
o fi t sp r i m a r yt a r g e t s[ 11, 12]. At 6–8 hours after infection
(p.i.), lymphotoxin α/β expressed on the surface of B cellsJournal of Biomedicine and Biotechnology 3
interacts with its cognate receptor on splenic stromal cells,
triggering type I interferon (IFN-α/β) secretion by the latter
[13,14].Within24hoursaftertheinitialinfection,beforethe
e n do ft h eﬁ r s tr o u n do fv i r a ld i v i s i o n ,t h i sﬁ r s tw a v eo ft y p e
I IFN secretion wanes. Subsequently, a second round of viral
infection occurs, this time in many more organs, making the
infection systemic.
Over the course of MCMV infection, several molecular
viral byproducts are generated due to the lytic nature of
the pathogen. Plasmacytoid DCs (pDCs) engulf infected
cell debris and recognize them through their endosomal
pattern recognition receptors (PRRs), that is, TLR3, TLR7
and TLR9; this recognition induces a second, much stronger
wave of type I IFN secretion (∼3 6h o u r sp . i )a sw e l la s
the production of other proinﬂammatory cytokines (IL-12,
IL-6, IL-1β,T N F - α,e t c . )[ 15–17]. In parallel, the presence
of MCMV particles in the cytoplasm of pDCs can lead to
viral recognition by the NOD-like and RIG-I-like helicase
sensors resulting in secretion of more pro-inﬂammatory
cytokines; these molecules probably also contribute to pDC-
independent secretion of type I IFN [18–20].
Conventional DCs (cDCs) are one of the many cell types
that are initially infected by MCMV. In response to infection,
they secrete IL-12, IL-18, IL-15 (trans-presented), and type
I IFN all of which are required for NK cell activation.
Indeed, diﬀerent NK cell eﬀector functions require diﬀerent
cytokine inputs for their initiation: while the IFN-αβ/STAT1
pathwayis necessary for cytotoxicityand initialproliferation,
NK cell IFN-γ production during the ﬁrst 2 days following
infection necessitates IL-18 or IL-12/STAT4 (Figure 2(a)i)
[21–23]. Moreover, the IFN-γ secreted by infected cDCs,
along with macrophage-secreted MIP1-α, are critical for
the control of viral loads in the liver and lungs [24].
IFN-γ is also important for perforin-dependent control of
viral replication in the spleen [25]. Once activated, NK
cells start to eliminate infected cDCs and TNF-α-secreting
macrophages, thus reducing the immunopathology caused
by this cytokine [26]. In short, the initial NK cell response
against MCMV is mediated by a cytokine storm; it is rapid,
nonspeciﬁc, and global, involving NK cells with diverse Ly49
repertoires. Yet, it does not eﬀectively control viral spread.
Indeed, despite the high levels of antiviral cytokines
present in the serum, MCMV replication proceeds unhin-
dered. This is true for all inbred strains at day 1.5 after
infection. Yet, by day 3 p.i., mouse strains can be segregated
according to their NK cell-dependent control of MCMV
[27]. Most strains are susceptible to the virus, while a select
few are resistant. These strains include C57BL/6 (B6) and
MA/MyJ mice, whose resistance depends on their strain-
speciﬁc activating Ly49 receptor, as well as PWK/Pas and
NZW/LacJ mice, whose resistance is not yet characterized
[27–29].
3.SpeciﬁcRecognitionofMCMV-Infected Cells
3.1. Ly49H/m157 Axis. MCMV resistance in B6 mice
depends on the presence of the activating Ly49H receptor on
the surface of their NK cells [30–32]. In this mouse strain,
approximately 50% of NK cells express the receptor. Ly49H
binds directly to m157, a MCMV-encoded glycoprotein
with structural homology to host MHCI molecules; unlike
the latter, however, m157 is a GPI-anchored protein, does
not associate with β2-microglobulin, or present peptides at
the surface of the cell [33–35]. During the early phase of
the infection, Ly49H-m157 ligation initiates an activating
signaling cascade, resulting in clonal proliferation of Ly49H+
NK cells, killing of infected cells, and secretion of cytokines
(IFN-γ,M I P 1 - α,T N F - α, etc.), all of which result in the
reduction of viral loads (Figure 1(a)).
Theimportanceofthisreceptor-ligandpairinthecontrol
of MCMV infection was demonstrated by numerous studies.
In the case of the virus, resistant mice became susceptible
upon infection with a m157-deletant MCMV (Δm157)
(Figure 1(b))[ 36]. As for the host, deletion of Ly49H gene or
deletionorlossoffunction mutationoftheDAP12genewere
shown to render mice susceptible to MCMV infection, as
revealed by high viral titers[37–39]. Conversely, transgenesis
of Ly49H into initially susceptible strains was found to make
them resistant to MCMV [40].
Once the interaction between Ly49H and m157 was
established as an essential component of MCMV resistance
in B6 mice, the nature of this interaction was investigated.
Structural analysis, molecular modeling, and targeted muta-
tions of both m157 and Ly49H have shown the importance
of the receptor homodimerization domain. Indeed, Ly49H
receptors carrying mutations in this region display reduced
m157 recognition, while mutations in the putative ligand-
binding regions had limited impact on this same interaction
[41]. In the same vein, mutation of buried residues required
for correct m157 folding (α0:α2 helix interactions) altered
the ability of the viral molecule to bind Ly49H, while muta-
tions in the exposed and scattered residues across the entire
m157 structure did not [42]. Furthermore, posttranslational
modiﬁcations can also aﬀect Ly49H-m157 binding. Indeed,
given the four putative N-glycosylation motifs (NXT/S)
of m157, a variety of glycosylated isoforms were found
to be expressed on the surface of MCMV-infected cells.
Although these isoforms are also recognized by Ly49H, their
binding stability and half-life are increased as compared to
the unglycosylated m157 [43]. These results reveal a quite
tolerant recognition of m157 by Ly49H where several amino
acid substitutions are necessary in order to disrupt m157-
Ly49H interactions. Such a molecular arrangement could
allowLy49Htorecognizevariablem157molecules,emerging
as the MCMV attempts to escape immune recognition.
From an evolutionary standpoint, capture of the H-
2 gene by MCMV is thought to have initiated a cascade
of events leading to the emergence of the Ly49H-m157
interaction. Originally, this capture could have allowed the
virus to exploit a MHCI homologue capable of triggering
inhibitory Ly49 receptors. Since the Ly49 locus evolves
rapidly, any inhibitory receptor could have been converted
to an activating one, including those with binding speciﬁcity
for m157 [44, 45]. In support of this, m157 can be
bound by the inhibitory Ly49I receptor from 129/J mice;
unfortunately, the involvement of Ly49I in susceptibility to
MCMV infection could not be assessed due to a defect in4 Journal of Biomedicine and Biotechnology
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Figure 1:Multiple modes ofLy49-NK cell-dependent recognition ofMCMV-infected cell. NK cell-dependent detection ofMCMVinfection
occurs through diﬀerent Ly49 receptors and viral proteins. (a, b) Ly49H-m157, operating in C57BL/6 mice; (c, d) Ly49P-m04:H-2Dk or
Ly49G-H-2Dk, operating in MA/MyJ mice; (e, f) Inhibitory Ly49-H-2:m04, operating in BALB mice. (a, c) Triggering of the activating Ly49
receptors by their viral ligand, m157, or by their virally modiﬁed self-ligands, m04:H-2Dk, leads to NK cell cytotoxicity, proliferation, and
secretion of cytokines. (b, d) The absence of these ligands prevents NK cells from recognizing and responding to infected cells. (e) However,
triggering of inhibitory Ly49 receptors by virally modiﬁed self-ligands results in NK cell unresponsiveness during the infection. (f) NK
cell responsiveness is restored upon infection with a deletant virus lacking the protein required for modifying self-ligands. WT MCMV:
Wild-type MCMV, Δm157: MCMV lacking m157, Δm04: MCMV lackingm04, (+): activation, (-): inhibition.
NK cell signaling within this strain [33]. Recently, additional
inhibitory Ly49 receptors, namely, Ly49C from the B6,
BALB/c, and NZB strains, have been shown to interact with
the m157 obtained from wild-derived MCMV isolates [46].
Interestingly, Ly49C-speciﬁc recognition of nonlaboratory
strain-MCMV-infected cells did not seem to interfere with
Ly49H-mediated NK cell activation and theensuing antiviral
response in B6 mice. The dominant Ly49H recognition of
m157issupportedbythefact thatsequentialpassage ofwild-
type(WT)MCMV in B6miceleads totheemergenceof“NK
cell-escape” m157 variants, which evade Ly49H-mediated
NK cell recognition [47]. Nevertheless, the m157 proteins of
MCMV strains isolated from wild mice are highly variable,
indicatingthatoutsideoflaboratory settings, bothinhibitory
and activating Ly49 receptors could be targeted by the virus.
Inany case,thefactthatm157,oneofmany MCMV-encoded
proteins, can be recognized by diﬀerent Ly49 receptors, both
activating and inhibitory, suggested that other mechanisms
of MCMV recognition might exist in other mouse strains.
3.2. Ly49P/m04/H-2Dk Axis. In this second mechanism of
MCMV-infected cell recognition, anactivating Ly49receptor
recognizes “altered” self-MHCI molecules rather than a viral
MHCI homologue; this alteration of self-MHCI molecules
stems from their association with viral protein. This type
of recognition could be used by NK cells from MA/MyJ
mice, which are resistant to MCMV even though they lack
Ly49H. Indeed, MA/MyJ resistance has been associated with
a genetic interaction between the NKC and the H-2k loci or
the H-2k locus alone [48–50]. At the cellular level, MA/MyJ
resistance is correlated with the expression of the activating
Ly49P receptor. This receptor can recognize infected cells
given the surface expression of two speciﬁc elements: the
viral m04/gp34 protein in association with H-2Dk molecules
(Figure 1(c)). In order to dissect the contribution of H-2
to this recognition, chimeric H-2 molecules were produced,
in which domains were swapped between H-2Db and H-
2Dk; these chimeric molecules were used to show that
the H-2Dk-binding platform in particular is required for
this recognition. Furthermore, the ectopic expression of
m04/gp34 alone cannot stimulate Ly49P-bearing reporter
cells in the absence of infection. This stimulation, however,
is restored when target cells are infected with a viral deletion
mutantlackingm04(Δm04MCMV),suggestingthatanother
host or viral factor is necessary for Ly49P/m04/H-2Dk-
mediated recognition of infected cells. m04/gp34 is crucial
for the in vivo NK cell response in MA/MyJ mice, sinceJournal of Biomedicine and Biotechnology 5
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Figure 2: Diﬀerent regulatory roles of Ly49H+ NK cells in adaptive immune responses. (a) Ly49H+ NK cells rapidly control viral replication
and protect cDCs from MCMV infection. This allows for rapid recruitment and priming of CD8+ T cells and reduces viral and self-
immunopathology. (i) Interaction of NK cells with MCMV-infected conventional dendritic cells (cDCs) induces the former’s proliferation
and cytotoxicity via IFN-α/β or secretion of IFN-γ via IL-12/IL-18. (ii) Ly49H+ NK killing of infected cDCs will also reduce the priming of
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responses, thus reducing immunopathology. (b) Schematic representation of NK cell proliferative responses upon primary and secondary
MCMV infections. ↑:i n c r e a s e ,↓: decrease.
normally resistant MA/MyJ mice are unable to control viral
replication following infection with Δm04 MCMV [51]
(Figure 1(d)).
T h ei m p o r t a n c eo fH - 2 D k in the resistance of MA/MyJ
mice was also demonstrated in vivo:( 1 )b yt h ec r e a t i o n
of an H-2k congenic mouse panel; (2) by the transgenesis
of H-2Dk into susceptible H-2b m i c e .I nb o t hc a s e s ,t h e
mice became capable of controlling the viral infection, as
opposed to H-2b animals [50, 52, 53]. Xie et al. tested
their H-2k congenic mouse panel further and showed that
Ly49G+ NK cells expanded preferentially in these mice at
90 hours p.i. Their resistance to MCMV infection was
abrogated following depletion of Ly49G+ NK cells, which
suggests that Ly49G is somehow involved [52, 53]. Since
an inhibitory receptor cannot directly mediate resistance to
MCMV, the authors hypothesized that appropriate licensing
via Ly49G:H-2Dk interaction renders NK cells functional,
capableof subsequentlyrecognizing and eliminating MCMV
through Ly49P/m04/H-2Dk (Figure 1(c)). Nevertheless, it
remains unclear how or if licensing contributes to the ability
of NK cells to resolve MCMV infection. Indeed, it has
recently been shown that unlicensed NK cells respond better
to MCMV infection [54]. Regardless of the role of licensing,
the available evidence suggests that several Ly49 receptors
might be involved in the control of MCMV infection in
MA/MyJ mice.
3.3. Inhibitory Ly49/m04/MHCI Axis. The contribution of
inhibitory Ly49 receptors to the NK cell-mediated control
of MCMV infection has recently been evaluated. Indeed,
studies using BALB mice show that the presence of Ly49
inhibitory receptors negatively impacts early MCMV resis-
tance, that is, it makes mice susceptible to the virus [55].
BALB mice are considered susceptible, that is to say that
they are unable to control the replication of WT MCMV
in the spleen at day 3 p.i. However, infecting these mice
with Δm04 MCMV results in a signiﬁcant reduction of viral
loads in this organ and increased NK cell proliferation in
a H-2-dependent manner. Indeed, BALB mice of the H-
2k (BALB.K) background showed the greatest reduction in
viral load upon infection with Δm04 MCMV, whereas none
was seen in H-2b mice (BALB.By); the viral load reduction
in H-2d mice (BALB/c) was an intermediate value between
that of H-2k and H-2b mice. This reduction in viral load is
due to the absence of m04/gp34, which maintains surface
expression of MHCI molecules, and the action of activating
r e c e p t o r ss u c ha sN K G 2 D .A ss u c h ,i nW TM C M V - i n f e c t e d
cells, suﬃcient levels of MHCI molecules are displayed on
the cell surface; this allows inhibitory Ly49 receptors to be
triggered and to deliver their inhibitory signal, the result
of which is the unresponsiveness of NK cells (Figure 1(e)).
In the case of Δm04 MCMV infection, the expression of
MHCI molecules is severely downregulated, allowing NK6 Journal of Biomedicine and Biotechnology
cell activation through the “missing-self” mechanism and
improved control of viral spread (Figure 1(f)). Furthermore,
viral loads were shown to return to high levels following
depletion of certain inhibitory Ly49+ NK cell fractions
during Δm04 MCMV infection of H-2d BALB mice. This
eﬀect was more pronounced following Ly49G+ NK cell
depletionthan Ly49C+ orLy49A+ NKcell depletion.In sum-
mary altered self-recognition by activating Ly49 receptors,
requiring the presence of self-MHCI molecules associated
with viral products, implicates involvement of inhibitory
Ly49 receptors, which depending on mice strain can have
opposite eﬀects. Thus, when the predominant signal is
m04-dependent activation (e.g., MA/MyJ via Ly49P), m04
ablation allows enhanced viral replication; however, when
the predominant signal is m04-dependent inhibition (e.g.,
BALBviaLy49G/A),absence ofm04allows enhanced control
of virus replication.
In short, these ﬁndings suggest that the early, NK cell-
dependent control of viral replication is not solely due to
activating Ly49 receptors,butratherthatitinvolvesadelicate
interplay between signals generated by both activating and
inhibitory receptors.
4.Beyond Natural Killing:Regulationof
Inﬂammatory andAdaptiveResponsesby
NK Cells
NK cells have classically been thought of as eﬀectors of the
antiviral response through their ability to directly eliminate
infected cells. However, recent evidence demonstrates that
their role extends beyond that of eﬀector lymphocytes
into regulators of the inﬂammatory and adaptive immune
response against viral infection. More speciﬁcally, Ly49H+
NK cells are essential for the protection and preservation
of cDCs, which can themselves stimulate NK cells and
potentiate their response [56, 57]. Nevertheless, infection
does occur; NK cell-dependent elimination of cDCs and, in
particular, macrophages, reduces the secretion of TNF-α,a
major contributor to hemophagocytic lymphohistiocytosis
syndromeduringMCMVinfection[26].Inaddition,Ly49H-
m157-dependent reduction of viral burden decreases the
duration and intensity of pDC activation, which limits very
high systemic levels of type I IFN and other cytokines that
can be detrimental to the host [32, 58–60]. In doing so, NK
cells also accelerate the recruitment and expansion of anti-
MCMV speciﬁc CD8+ Tc e l l s ,a si tw a ss h o w nt h a ti nm i c e
devoid of Ly49H, the appearance of CD8+ T cells is delayed
by ∼1d a y( Figure 2)[ 57].
Triggering by m157 is essential for Ly49H+ NK cell
ampliﬁcation and maintenance. In the context of MCMV
infection, signaling through Ly49H/DAP12 induces NK cell
clonal proliferation, ultimately leading to an increase in the
Ly49H+ NK cell frequency from 50% to 80% and clearance
of the virus in the spleen and liver by day 6 p.i. [32].
Conversely, in Ly49H−/− mice, the overall amount of NK
cells declines past uninfected levels, leading to high viral
titers in the spleen at the same time point [59]. Another
study, by Lee et al., attempted to dissect the role of Ly49H
in various aspect of the NK cell response using Ly49h
or perforin 1( Prf1) knockout mice. For instance, Ly49H-
expressing Prf1−/− mice were susceptible to MCMV infec-
tion, eventhoughLy49H+ NKcellsproliferatedsubstantially.
Although in these mice the NK cytotoxic function was
absent, they survived a dose that killed Ly49h−/− Prf1−/−
double-knockout mice. Therefore, Ly49H expression was
protective. This was explained by the fact that Ly49H+ NK
cells secreted IL-10, a potent immunosuppressive cytokine
capable of limiting CD8+ T cell cytotoxicity as well as IFN-
γ and TNF-α secretion (Figure 2(a)ii) [59]. Thus, Ly49H is
required for the maintenance of NK cells until late time-
points after infection, allowing them to exert a regulatory
function over CD8+ T cells and the immunopathology they
can cause.
Paradoxically, the presence of activating Ly49 receptors
can also be detrimental to the subsequent adaptive immune
response by promoting viral persistence. For example, while
Ly49H+ mice could clear infected cDCs better than their
Ly49H− counterparts, killing of these antigen-presenting
c e l l s( A P C s )p r e v e n t e dt h e mf r o mp r i m i n gn a ¨ ıve, virus-
speciﬁc T cells [61]. This lack of appropriate T-cell priming
in Ly49H+ miceresulted inthereducedactivation, cytotoxic-
ity,IFN-γ secretion,andmaintenanceofCD8+ Tcells,aswell
as the reduced IFN-γ secretion and maintenance of CD4+
T cell, contributing to MCMV persistence in the salivary
glands (Figure 2(a)ii). However, MCMV-infected, immature
cDCs have also been shown to induce anergy, poor eﬀector
functions, and inferior recall responses in CD4+ and CD8+ T
cells[62].Furtherresearch isneededtodeterminetheprecise
eﬀect of cDC clearance in the overall response to the virus.
Nevertheless, Ly49H+ NK cell recognition and removal of
MCMV-infected cells can unquestionably shape the course
of the adaptive immune response.
5.Memory-Like NK Cells
Another unforeseen NK cell role was evidenced by the
discovery that, following activation, NK cells acquire fea-
tures seen in memory T-cell populations. The existence of
memory-like NK cells was ﬁrst hinted at in a study of
chemically-induced contact hypersensitivity (CHS). In this
model, mice lacking T and B lymphocytes, the classical
mediators of CHS, remained able to elicit an inﬂammatory
responsethroughhepaticNKcells,asmeasuredbydermatitis
[63]. Sun et al. [64] followed up on this observation using
an MCMV model of infection and adoptive transfer into
DAP12−/− mice. The investigators noticed that only Ly49H+
NK cells underwent speciﬁc clonal expansion before con-
traction and persisted for up to 70 days p.i. This was rather
astonishing as the generally accepted half-life of mature NK
c e l l si s7t o1 7d a y s[ 65]. Importantly, irrespective of initial
transfer numbers the frequency of the MCMV-speciﬁc NK-
cell response was similar to primary T-cells responses. They
also observed that these long-lived, memory-like NK cells
werem157-speciﬁcandhadsuperioreﬀectorresponsesupon
rechallenge with MCMV as compared to na¨ ıve NKcells [64].Journal of Biomedicine and Biotechnology 7
The existence of memory-like NK cells was also con-
ﬁrmed by transferring cytokine-activated NK cells into na¨ ıve
hosts and observing that they could still be detected as
far as 22 days after transfer [66]. These memory NK
cells were found to have similar cytotoxic activity to that
of their na¨ ıve counterparts. Moreover, they were unable
to constitutively produce IFN-γ yet upon restimulation
produced signiﬁcantly more of this cytokine than na¨ ıve
NK cells. More recently, again in the CHS model, virus-
speciﬁc memory-like NK cells were generated in response
to inﬂuenza virus, VSV or HSV-1 infection. In this case, the
adoptivetransfer ofspeciﬁc,virus-sensitized hepaticNKcells
into naive mice improved their survival following infection
with a lethal dose of virus; thiswas dependentonthe CXCR6
chemokine receptor expressed on NK cells [67].
All of these experiments have shown that innate immune
c e l l sc a nr e t a i na ni n t r i n s i cm e m o r yo fp r i o ra c t i v a t i o n ,a
function until now restricted to antigen-speciﬁc, adaptive
immunelymphocytes.However,most oftheaforementioned
studies were performed with immunodeﬁcient donor and
recipient mice. Given the adaptabilityofthe immune system,
it is possible that donor NK cells, once transferred into
these recipients, may have taken up more responsibility (i.e.,
memory status) than they normally would in WT animals
in order to compensate for the absence of T and B cells.
As for the work performed by Sun et al., even though their
donor NK cells came from WT mice, they were transferred
into neonate animals, whose adaptive immune responses are
arguably as ineﬀective as that of immunodeﬁcient mice.
6.Conclusions
Since their discovery over 30 years ago, it has become clear
that NK cells possess numerous functions, going beyond
their original “natural killers of tumors” role. Among these,
they act as a ﬁrst line of defense in the context of infection
with a variety of pathogens, in particular viruses. Humans
havebeen coevolvingfor millions ofyears with some ofthese
viruses, namely CMVs; therefore, they “know us better than
we know ourselves”, having shaped our immune system and
been shaped in return.
Mouse models of MCMV infection revealed that NK
cells are not merely “killers” of infected targets, but very
complex lymphocytes endowed with the molecular machin-
ery necessary to perform a broad spectrum of functions.
As part of the innate system, NK cells can immediately
react to an infectious insult via ﬁxed, germ-line encoded
receptors that recognize pathogen-associated motifs. As the
infection progresses, NK cells adapt, modulating the level
of inﬂammatory mediators produced during the initial steps
of infection. Finally, as adaptive responders, NK cells show
clonal expansion, maintenance, and memory of previous
insults in the case of reinfection.
Nevertheless, several questions remain: do NK cells
recognize infections other than MCMV with their Ly49
repertoire of receptors? Can triggering of other NK receptors
by MCMV-infected cells induce the same NK cell outcomes
as in the Ly49H-m157 model (e.g., clonal expansion, mem-
ory, etc.)? What of other pathogens or diﬀerent host species?
Why does the host express so many diﬀerent NK receptors
targeting MCVM, several with opposite eﬀects on NK cell
activity (i.e., inhibitory versus activating)? Does the host
beneﬁt from the infection? If so, how? The possible paths
of investigation are plentiful. As more inquiries are resolved,
which is currently the case in the thriving ﬁeld of NK cells
in cancer, we will be able to harness the power of these
lymphocytes in the treatment of infectious diseases [68, 69].
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